ACE2 Is a Prognostic Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma: Implication for COVID-19

Figure 3

ACE2 served as a biomarker in KIRC. (a) High ACE2 expression in KIRC was associated with a favorable overall survival (GEPIA). (b) High ACE2 expression in KIRC was associated with a favorable disease-free survival (GEPIA). The median value of ACE2 expression was utilized to identify high/low ACE2 expression patients.

(a)

(b)